Anzeige
Meldung des Tages: Antimon wieder im Fokus: ATMY erreicht Allzeithoch – Verteidigungsnachfrage treibt den Markt

ResMed News

Aktie
WKN:  895878 ISIN:  US7611521078 US-Symbol:  RMD Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
219,85 $
+0,34 $
+0,15%
187,61 € 24.04.26
Depot/Watchlist
Marktkapitalisierung *
30,44 Mrd. €
Streubesitz
33,73%
KGV
27,07
Dividende
2,01 EUR
Dividendenrendite
0,98%
Nachhaltigkeits-Score
51 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 7,13: MG6X5L
Werbung

ResMed News

03.03.26 - GlobeNewswire
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains
03.09.25 - GlobeNewswire
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care
27.08.25 - GlobeNewswire
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, ...
21.08.25 - GlobeNewswire
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
Milestones underscore Resmed’s leadership and commitment to delivering life-​changing health technology that people love
18.08.25 - GlobeNewswire
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Mowad-​Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and ...
15.05.25 - GlobeNewswire
Resmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
SAN DIEGO and LONDON and DUBLIN and SYDNEY, May 15, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on ...
01.05.25 - GlobeNewswire
Resmed Acquires VirtuOx
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers
21.04.25 - GlobeNewswire
Resmed Names Salli Schwartz as Chief Investor Relations Officer
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community
19.03.25 - GlobeNewswire
New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer
Largest ever meta-​analysis on the long-term benefits of CPAP therapy, published in The Lancet Respiratory Medicine, found that in people with sleep apnea, CPAP therapy lowered ...
11.03.25 - GlobeNewswire
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Brand Evolution Unites Brands Under One Resmed Identity to Make Better Sleep and Breathing Health More Accessible to Everyone
26.02.25 - GlobeNewswire
ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships
21.11.24 wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Frische Q-Zahlen von: CTS Eventim, Intuit, Gap, Julius Bär, DFV sowie Deere & Co
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
30.09.24 wallstreetONLINE Redaktion
Ihre wichtigsten Termine: Alle Analysten-Augen auf: Roche und ResMed sowie US-Konjunktur­daten
Gut geplant in den Tag. Mit dem wO-​Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine ...
10.09.24 - GlobeNewswire
Vaping Expected to Increase COPD Health and Economic Burden by 2050
New ResMed-​supported research presented at ERS 2024 projects future Chronic Obstructive Pulmonary Disease (COPD) burden in Western Europe, accounting for increased air ...
13.08.24 - PR Newswire
TSX Venture Exchange Stock Maintenance Bulletins
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire
10.08.24 - Aktienwelt360
ResMed: Deine nächste Top-Investition im Gesundheitssektor?
Wusstest du, dass fast eine Milliarde Menschen weltweit an Schlafapnoe leiden? Diese weitverbreitete, aber oft unbeachtete Erkrankung öffnet für Unternehmen wie ResMed (WKN ...
10.06.24 - GlobeNewswire
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of ...
15.03.24 - GlobeNewswire
ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
36,000 people across 17 markets responded to the company’s fourth annual survey. 40% of respondents get no more than three nights of good sleep per week. More than one-third ...
20.12.23 - Aktienwelt360
Sei positiv gewarnt: Denn diese beeindruckende Medizintechnik-Aktie könnte schon 2024 wieder auf die Überholspur wechseln!
Im Supermarkt greifen bei Sonderangeboten ja ganz gerne viele beherzt zu. An der Börse sieht die Situation aber in der Regel etwas anders aus. Gibt es Aktien zu niedrigen Kursen ...
11.12.23 - Julius Weiß
Neue Basiswerte
Pünktlich zum Wochenbeginn der dritten Adventwoche gibt es neue Basiswerte für die Produkte von HSBC. Welche Unternehmen konkret neu im Sortiment sind, erfahren Sie hier.

Newssuche

Videos

newspaper
20.04.26 +3,18%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »